BBH Price Forecast & ETF Analysis. Dividend · Expense Ratio · Holdings · NAV · RSI · MACD | US Stocks Today
Full metrics table
| Category | Global or ExUS Equities - Industry Sector | Expense | 0.35% | Return% 1Y | 40.15% | Total Holdings | 26 | Perf Week | 0.41% | Volume | 6,558 |
| Asset Type | Equities (Stocks) | AUM | $503M | Return% 3Y | 18.73% | NAV | $247.16 | Perf Month | 1.82% | Avg Volume | 0.01M |
| ETF Type | Global Equities | Dividend TTM | $0.96 (0.38%) | Return% 5Y | 5.43% | 52W High | -0.65% | Perf Quarter | 19.73% | Rel Volume | 0.62 |
| Active/Passive | Passive | Div Gr. 3/5Y | 8.47% 9.47% | Return% 10Y | 9.35% | 52W Low | 41.69% | Perf Half Y | 35.88% | Prev Close | $247.39 |
| IPO | 2011/12/21 | Flows% 1M | 1.95% | Return% SI | 14.4% | RSI (14) | 60.14 | Perf YTD | 31.99% | Price | $249.80 |
| Beta | 0.71 | Flows% 3M | 4.52% | Flows% YTD | 2.95% | Flows% 1Y | 3.28% | Perf Year | 40.27% | Volatility(W/M) | 1.53% 1.9% |
| SMA20 | 3.08% | SMA50 | 4.18% | SMA200 | 21.42% | ATR | 4.56 | ||||
VanEck Biotech ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
The top 10 make up 70% of the fund
Concentrated in a few names. When they swing, the ETF swings with them.
AMGN Amgen Inc 15.25% 2 
GILD Gilead Sciences Inc 12.79% 3 
VRTX Vertex Pharmaceuticals Inc 9.10% 4 
REGN Regeneron Pharmaceuticals Inc 6.21% 5 
RVMD Revolution Medicines Inc 5.27% 6 
ARGX Argenx SE 4.97% 7 
NTRA Natera Inc 4.92% 8 
IQV IQVIA Holdings Inc 4.31% 9 
ALNY Alnylam Pharmaceuticals Inc 3.83% 10 
BIIB Biogen Inc 3.63% Largest sectors first.
Over the past 1 year, on the higher side
1% below its 1-year high.
Traded less than usual. That is 62% of its average volume.
Holding long would have paid off
Bought 5 years ago, your return today would be +26.8%. The S&P 500 did +70% over the same period.
Tap to view numbers
The price swings a lot
At its worst (August 2021) it fell 40% and took 1516 days to recover.
Tap to view numbers
The dividend is on the small side
Pays 0.38% annually in dividends.
Tap to view numbers
A little money is flowing in
Over the past year, new money equal to 3.3% of assets came in.
Tap to view numbers
TECL Direxion Daily Technology Bull 3X ETF 5.7B 
BULZ MicroSectorsTM Solactive FANG Innovation 3X Leveraged ETNs 2.8B 
FNGU MicroSectors FANG+ 3X Leveraged ETNs 2.4B 
ROM ProShares Ultra Technology 2x Shares 1.2B 
FNGO MicroSectors FANG+Index 2X Leveraged ETNs 716M 
IDNA iShares Genomics Immunology and Healthcare ETF 0.47% 
MEDI Harbor Health Care ETF 0.8% 
GDOC Goldman Sachs Future Health Care Equity ETF 0.75% 
MEDX Horizon Kinetics Medical ETF 0.85% 
JDOC JPMorgan Healthcare Leaders ETF 0.65% 
HAUZ Xtrackers International Real Estate ETF 0.1% 
VNQI Vanguard Global ex-U.S. Real Estate ETF 0.12% 
PBPH Portfolio Building Block World Pharma and Biotech Index ETF 0.13% 
FAQ
How many holdings does BBH have?
BBH holds a total of 26 securities, with an AUM of approximately $503M.
Does BBH pay dividends (distributions)?
BBH's distribution yield is approximately 0.38%.
What is the 52-week high and low for BBH?
BBH has recorded a 52-week high of $251.45 and a low of $176.30.
